Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease
Science Advances · 2024
DOI: 10.1126/sciadv.adj5942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Guogang Xu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Healt…. Hauptthemen laut MEDLINE: Acetate-CoA Ligase, Cellular Senescence, Mitochondria, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Acetyl-CoA synthetase short-chain family member 1 (ACSS1) uses acetate to generate mitochondrial acetyl-CoA and is regulated by deacetylation by sirtuin 3. We generated an ACSS1-acetylation (Ac) mimic mouse, where lysine-635 was mutated to glutamine (K635Q). Male Acss1 K635Q/K635Q mice were smaller with higher metabolic rate and blood acetate and decreased liver/serum ATP and lactate levels. After a 48-hour fast, Acss1 K635Q/K635Q mice presented hypothermia and liver aberrations, including enlargement, discoloration, lipid droplet accumulation, and microsteatosis, consistent with nonalcoholic fatty liver disease (NAFLD). RNA sequencing analysis suggested dysregulation of fatty acid metabolism, cellular senescence, and hepatic steatosis networks, consistent with NAFLD. Fasted Acss1 K635Q/K635Q mouse livers showed increased fatty acid synthase (FASN) and stearoyl-CoA desaturase 1 (SCD1), both associated with NAFLD, and increased carbohydrate response element–binding protein binding to Fasn and Scd1 enhancer regions. Last, liver lipidomics showed elevated ceramide, lysophosphatidylethanolamine, and lysophosphatidylcholine, all associated with NAFLD. Thus, we propose that ACSS1-K635-Ac dysregulation leads to aberrant lipid metabolism, cellular senescence, and NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.
- Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.
- Department of Radiation Oncology, Robert Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
- Division of Diabetes, UT Health San Antonio, San Antonio, TX, USA.
- Department of Biochemistry and Structural Biology, UT Health San Antonio, San Antonio, TX, USA.
- Department of Pharmacology, Mays Cancer Center, Transplant Center, UT Health San Antonio, San Antonio, TX, USA.
ORCID-Profile: Guogang Xu, Songhua Quan, Joseph Schell, Mahboubeh Varmazyad, Prethish Sreenivas, Meixia Pan, Xianlin Han, Juan Pablo Palavicini, Peng Zhao, Xiaoli Sun, Erik D Marchant, Blake B Rasmussen, Guannan Li, Sakie Katsumura, Masahiro Morita, Erin Munkácsy, Nobuo Horikoshi, E Sandra Chocron, David Gius
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Xu, G., Quan, S., Schell, J., Gao, Y., Varmazyad, M., Sreenivas, P., Cruz, D., Jiang, H., Pan, M., Han, X., Palavicini, J. P., Zhao, P., Sun, X., Marchant, E. D., Rasmussen, B. B., Li, G., Katsumura, S., Morita, M., Munkácsy, E., …, & Gius, D. (2024). Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease. Science Advances. https://doi.org/10.1126/sciadv.adj5942
Vancouver
Xu G, Quan S, Schell J, Gao Y, Varmazyad M, Sreenivas P, et al. Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease. Science Advances. 2024. doi:10.1126/sciadv.adj5942
BibTeX
@article{Xu2024,
author = {Xu, Guogang and Quan, Songhua and Schell, Joseph and Gao, Yucheng and Varmazyad, Mahboubeh and Sreenivas, Prethish and Cruz, Diego and Jiang, Haiyan and Pan, Meixia and Han, Xianlin and Palavicini, Juan Pablo and Zhao, Peng and Sun, Xiaoli and Marchant, Erik D and Rasmussen, Blake B and Li, Guannan and Katsumura, Sakie and Morita, Masahiro and Munkácsy, Erin and Horikoshi, Nobuo and Chocron, E Sandra and Gius, David},
title = {Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adj5942}
}
EUVIMED